Hyperglycemia, diabetes, and de novo diabetes in patients hospitalized in intensive care units for COVID-19 in Colombia: Results from a longitudinal cohort study

Abstract Introduction Hyperglycemia and diabetes have been identified as risk factors for severe COVID-19 and death, with a high rate of reported de novo diabetes. We evaluated their incidence and relationship with adverse outcomes in critically ill COVID-19 patients. Methods Prospective single-center longitudinal cohort study in adults hospitalized in intensive care units for confirmed COVID-19. ROC curves for serum glucose and glycated hemoglobin were plotted in relation to 60-day mortality. A Cox proportional hazards model was used to assess the association of diabetes and de novo diabetes with 60-day mortality. Results 547 patients were included, with a mean age of 59.8 years; 133 (24.3%) had a history of diabetes, and 67 (12.2%) had de novo diabetes. At 60 days, 317 (57.9%) had died. For mortality, the AUC for glucose at admission was 0.55 (95% CI: 0.48 – 0.62) and 0.51 (95% CI: 0.41 – 0.62) for glycated hemoglobin. In the Cox model, diabetes had an HR of 0.888 (95% CI: 0.695 – 1.135, p: 0.344), history of DM had an HR of 0.881 (95% CI: 0.668 – 1.163, p: 0.371), and de novo diabetes had an HR of 0.963 (95% CI: 0.672 – 1.378, p: 0.835). Conclusion There was a high incidence of de novo diabetes in patients hospitalized in intensive care for COVID-19. Neither hyperglycemia, history of diabetes, nor de novo diabetes were associated with the development of complications or 60-day mortality.

• Publication year

  2025

• Venue

  The Journal of Critical Care Medicine

• Publication date

  2025-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2478/jccm-2025-0026PMID 40765540PMCID 12321255
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetes Mellitus and Its Association with Adverse In-Hospital Outcomes in Patients with COVID-19—A Nationwide Study

  2023cited by this paper
• Newly detected diabetes during the COVID-19 pandemic: what have we learnt?

  2023cited by this paper
• Glycemic control predicts SARS-CoV-2 prognosis in diabetic subjects

  2023influential reference
• Correction to: New-Onset Diabetes Mellitus in COVID-19: A Scoping Review

  2023cited by this paper
• Risks and burdens of incident diabetes in long COVID: a cohort study

  2022cited by this paper
• Trends and Risk Factors of In-Hospital Mortality of Patients with COVID-19 in Germany: Results of a Large Nationwide Inpatient Sample

  2022cited by this paper
• Diabetes and COVID-19; A Bidirectional Interplay

  2022cited by this paper
• Association of COVID-19 with diabetes: a systematic review and meta-analysis

  2022cited by this paper
• Newly Diagnosed Diabetes Mellitus During COVID-19: The New Pandemic – A Literature Review

  2022cited by this paper
• COVID-19 induced Diabetes: A novel presentation

  2022cited by this paper
• Diabetic ketoacidosis and COVID-19: what have we learned so far?

  2021cited by this paper
• COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus

  2021influential reference
• 16. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2022.

  2021influential reference
• Hyperglycemia and blood glucose deterioration are risk factors for severe COVID‐19 with diabetes: A two‐center cohort study

  2021influential reference
• Death by SARS-CoV 2: a Romanian COVID-19 multi-centre comorbidity study

  2020cited by this paper
• Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

  2020cited by this paper
• Glycemic control before admission is an important determinant of prognosis in patients with coronavirus disease 2019

  2020influential reference
• Fasting Plasma Glucose Level Independently Predicts the Mortality of Patients with Coronavirus Disease 2019 Infection: A Multicenter, Retrospective Cohort Study

  2020influential reference
• Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19

  2020cited by this paper
• The association of diabetes and the prognosis of COVID-19 patients: A retrospective study

  2020influential reference
• Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration

  2020influential reference
• Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID‐19

  2020influential reference
• Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

  2020cited by this paper
• The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: A single‐centre, retrospective, observational study in Wuhan

  2020cited by this paper
• Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes

  2009cited by this paper

• No citing papers are available for this paper.